To assess a possible relationship between hematocrit level and intraocular pressure (IOP) in both men and women.
Introduction
Glaucoma is the leading cause of blindness worldwide after cataracts. [1] It is the main reason for blindness among African Americans. [2, 3] In addition to older age, black race/ethnicity and a family history of glaucoma, elevated intraocular pressure (IOP) is a major risk factor for the development of open-angle glaucoma [4, 5] and it has been associated with progression of open-angle glaucoma. Lowering IOP is thus the major focus of glaucomatreatment. [6] [7] [8] Factors that affect IOP per se include older age, high blood pressure [9] elevated glucose levels [10] and elevated body mass index (BMI). [11] Several epidemiological studies have investigated the correlation between IOP and clinical and biochemistry tests. They found a weak correlation between IOP and hematocrit levels. [12] [13] [14] However, the studies did not account for sex differences in normal hematocrit levels, nor did they compare IOP in subjects with low or high hematocrit levels with those with a normal hematocrit level.
The aim of the current study, carried out on nonhospitalized men and women was to evaluate IOP measurements in relation to hematocrit levels. In addition, we calculated the risk of having an IOP of ≥18 mmHg in subjects with high or low hematocrit levels.
Materials and methods

Study population
The study population consisted of a cross-sectional sample of men and (nonpregnant) women aged 20 to 80 years referred by their employers for routine medical screening at a tertiary medical center in Israel between 2000 and 2013. None of the subjects was hospitalized at the time. Screening consisted of a thorough medical history and a complete physical examination along with a broad series of blood and urine tests, a chest x-ray, an electrocardiogram, an exercise stress test, a respiratory function test, and a full ophthalmology examination. For the purpose of this study, we used the data from each subject's most recent visit, as they may return for an annual visit. Subjects who had glaucoma or were scheduled for surgery for glaucoma were excluded from the study, as they were receiving IOP-lowering medication which might influence the effect of hematocrit on IOP.
All ophthalmology examinations were performed by an experienced ophthalmologist. IOP measurements using Goldmann applanation tonometry with fluorescein staining were measured in both eyes, with the patient in the sitting position, between 8:00 AM and 11:00 AM. All IOP measurements were performed using the same tonometer and were usually carried out by the same physician. For the study assessment we selected the right eye IOP measurements. We further categorized IOP as < 18 mmHg or ≥18 mmHg, according to the results of the Advanced Glaucoma Intervention Study 7 (AGIS). [15] Serum glucose levels were measured after an overnight 12-hour fast. Diabetes mellitus was defined as serum glucose levels ≥126 mg/dL or a known diagnosis of diabetes mellitus. Hypertension was defined as systolic blood pressure >140 mmHg and/or diastolic blood pressure >90 mmHg. Subjects in this group were identified as those with self-reported hypertension treated mostly by antihypertensive medications. Data on smoking habits and alcohol consumption were collected from direct questioning on the day of examination at the screening center.
A computer program was created to transfer all data, from each visit, into a spreadsheet Excel file. Statistical analysis was performed on this file.
For purpose of analysis, patients were divided into 3 groups according to hematocrit level (low, normal, and high), separately for men and women, and mean IOP was calculated for each.
The study was approved by the Helsinki Ethics Committee of Rabin Medical Center.
Statistical analysis
Baseline characteristics were compared between men and women using Student t test for continuous variables and x 2 test for categorical variables. Subjects were divided into 3 groups by hematocrit levels: normal (reference group), low and high, and compared for mean IOP [95% confidence interval (CI)] using multivariate analysis of variance (ANOVA) with Tukey's adjustment.
The odds ratios (ORs) and 95% CI for having an IOP of ≥18 mmHg were calculated by hematocrit level using logistic regression. Pearson correlation index was applied to assess the relationship between hematocrit level and IOP.
Univariate analyses were performed in Model 1. Model 2 was adjusted for age, and Model 3 was adjusted for age, hypertension, diabetes mellitus, and BMI. All analyses were performed using SAS v. 9.4. Statistical significance was set as a P < .05.
Results
Baseline characteristics
From 2000 to 2013, 18,424 subjects underwent screening at our medical center. Their clinical characteristics are presented in Table 1 . Mean [standard deviation (SD)] age of the sample was 46.0 (10) years; 68% were male and 32% female. Comparison of the men and women for background characteristics yielded no statistically significant differences in mean age (P = .367) or percentage of smokers (P = .174). Men had significantly higher rates of impaired fasting glucose, diabetes mellitus, hypertension, and alcohol consumption, and significantly higher mean values of BMI, low density lipoprotein cholesterol, and triglycerides (P < .001 for all). Women had significantly higher mean values of estimated glomerular filtration rate, serum thyroid stimulating hormone, and high density lipoprotein cholesterol (P < .001 for all).
Mean IOP by hematocrit level
The normal-range hematocrit level in men was 42% to 52%, with low levels defined as < 42% and high levels, as >52%. The normal-range hematocrit level in women was 37% to 47%, with low levels defined as <37%, and high levels, as >47%. Mean IOP (SD) measured 13.4 mmHg (2.5) in men and 13.0 mmHg (2.2) in women; this difference was statistically significant (P < .001). Mean (95% CI) IOP in subjects with low, normal, and high hematocrit levels were also found to be significantly different. These were found to be 13.3 (13.2-13.3), 13.5 (13.4-13.5), and 14.3 (13.5-15.2) mmHg for men, P < .001 and 12.9 (12.8-13.0), 13.0 (13.0-13.1), and 14.2 (12.9-15.6) mmHg for women, P = .014, respectively. After adjusting for age, hypertension, diabetes mellitus, and BMI the differences in IOP for different hematocrit levels remained significant for men but not for women ( Table 2 ). Figure 1 represents the above data as means ± standard error. Table 3 shows the ORs (95% CIs) of having IOP ≥18 mmHg in subjects with high or low hematocrit levels compared with subjects with normal hematocrit levels. In male subjects with a low hematocrit level, the OR (95% CI) of having IOP ≥18 mmHg was 0.761 (0.631-0.919) in the unadjusted model, 0.757 (0.626-0.914) when the model was adjusted for age, and 0.771 (0.638-0.932) when the model was adjusted for age, hypertension, diabetes mellitus, and BMI (P < .01). The risk in the women was not statistically significant (Table 3) .
Risk of IOP ≥18 mmHg by hematocrit level
Correlation of hematocrit levels and IOP
Pearson correlation analysis of the relationship between hematocrit and IOP level yielded r = 0.047 for men and Table 1 Baseline characteristics of the study population (18, 424 
Discussion
A large body of literature has described the association between elevated IOP and the development and progression of open-angle glaucoma. [6] [7] [8] In a recent study, our group found a significant relationship between BMI and IOP, with obese people having higher IOP levels. [11] The current study of the potential relationship between high hematocrit levels and IOP was prompted by previous findings of a correlation between plasma viscosity and glaucoma. Klaver et al [16] reported that subjects with glaucoma have both higher plasma viscosity levels and higher hematocrit levels than controls. Indeed, Vojnikovic [17] found that treatment with a blood hyper viscosity-reducing drug (Doxium) lowered elevated IOP in patients with diabetic retinopathy and patients with glaucoma.
Several epidemiological studies of the relationship between IOP and various clinical and biochemistry parameters reported a weak correlation with hematocrit levels. [12] [13] [14] However, these results were limited by a failure to distinguish between men and women, who have different normal-range hematocrit levels. Nor did the data compare IOP between groups of subjects with low or high hematocrit levels and those with normal hematocrit levels. In the current study, which sought to take these factors into account, we only found a very weak direct correlation between hematocrit levels and IOP, although as a whole, the men with low or high hematocrit levels had significantly lower or higher IOP levels, respectively, compared with men with normal hematocrit levels; this was even after adjusting for age, hypertension, diabetes mellitus, and BMI-all known factors of high IOP. Moreover, in male subjects with low hematocrit levels, the OR of having an IOP of ≥18 mmHg was found to be significantly lower than in those with normal hematocrit levels. We selected this cut-off because the Advanced Glaucoma Intervention Study 7 (AGIS) [15] shows that an IOP of ≥18 mmHg is associated with worsening visual fields on follow-up compared with an IOP of < 14 mmHg. The lack of a significantly increased OR of having IOP ≥18 mmHg in the high-hematocrit group, relative to the normalhematocrit group, can probably be attributed to the relatively small number of subjects with a high hematocrit level (n = 40). Studies in large groups of patients with polycythemia vera are needed to determine their risk of high IOP.
The sex difference in the current study was very clear. It may be explained by the generally lower hematocrit levels found in women compared with men. Although theoretically smokers may have increased hematocrit levels, no significant difference in smoking habits between the male and female subjects was found in our cohort. It is possible that the difference in favor of women may be related to their higher estrogen levels. Studies have shown that estrogen may lower ocular pressure by influencing the aqueous production in the eye and outflow systems. This effect on muscle tone and vascular resistance might be explained by increased activity of endothelial based nitric oxide synthase. [18] The main strength of this study is the inclusion of a large cohort (18,424 men and women) with complete datasets and a broad age range, largely representative of a western population. However, Table 3 Odds of having IOP ≥18 mmHg in subjects with high/low hematocrit compared with subjects with normal hematocrit.
OR (95% CI)
Logistic regression models by sex as the study group was drawn from a selected population attending an examination center, rather than a population sample, the findings may not be generalizable. Furthermore, the cross-sectional design precludes conclusions regarding causality. In summary, this study indicates that apart from the classic risk factors for increased IOP, including older age, diabetes mellitus, hypertension and BMI, IOP may also be influenced by hematocrit level in men.
